109.6 million people living in the U.S. have had a COVID booster, equal to 48.7% of the vaccinated population, the CDC’s tracker shows. Some 4.4 million people have had the new bivalent vaccines that target the latest omicron subvariants.
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use in children 5 to 11 years of age.
The news comes after Moderna MRNA, -3.19% said Friday that it has submitted its own request for its bivalent vaccine for children and adolescents aged 12 to 17, as well as a separate submission for 6- to 11-year-olds. The daily average for hospitalizations was down 14% at 29,835, while the daily average for deaths is up 15% to 432.Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began• French drug company Valneva SE VLA, +1.09% on Monday said it is in discussions with a prospective partner to get funding for a second-generation COVID vaccine, Dow Jones Newswires reported.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna, Pfizer Seek Authorization for Children’s BoostersPfizer/BioNTech and Moderna, the two biggest COVID vaccine makers for the United States, are both seeking emergency authorization from the FDA for bivalent vaccine boosters for children.
Read more »
Pfizer CEO tests positive for COVID-19 for second time in two monthsPfizer CEO Albert Bourla announced Saturday that he tested positive for COVID-19 — again.
Read more »
Pfizer CEO tests positive for COVID for a second timeAlbert Bourla had contacted the virus in August and took a course of the company's oral COVID-19 antiviral treatment, Paxlovid. He said he has not yet taken the new bivalent booster.
Read more »
Bivalent booster: Pfizer seeks to expand shot to 5- to 11-year-oldsPfizer is asking the FDA to expand use of its updated COVID-19 vaccine booster shot to children ages 5 to 11. The so-called bivalent shot is meant to be more effective against omicron variants of the coronavirus.
Read more »
Pfizer Requests Clearance for Children’s Covid-19 BoosterPfizer and BioNTech asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years, just as retooled shots for people 12 and older roll out.
Read more »
Pfizer seeks to expand omicron booster to 5- to 11-year-oldsPfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
Read more »